Company / Revenue per Share
Chemed Corp. Revenue per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$174.96
FY2025
5-year range
$134.22 / $174.96
FY2021-FY2025
Trend
+9.3%
vs FY2024
Sector context
#15 of 154
Health Care
What the data says
Among 154 Health Care companies, Chemed Corp. is in the top 10% for revenue per share. Revenue per Share has increased for 9 consecutive years, from $93.92 in FY2016 to $174.96 in FY2025.
Based on SEC 10-K filings.
174.96 in FY2025 with a 5-year CAGR of +6.6%. Top quartile in the Health Care sector.
Improved from $148.97 to $174.96 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +7.4%
- 5-Year CAGR
- +6.6%
- 10-Year CAGR
- -
Sector benchmark
Top 10% in Health CareTop 10% of 154This company $174.96 Sector average $123.99
▼
+41.1% above sector average
Key checks
Key Insights
- Chemed Corp.'s revenue per share has grown for 9 consecutive years.
- In FY2025, revenue per share increased 9.3% year-over-year.
- Ranks #15 out of 154 companies in the Health Care sector.
- Lowest revenue per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 4.70 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $174.96 | +9.3% |
| FY2024 | $160.10 | +7.5% |
| FY2023 | $148.97 | +5.4% |
| FY2022 | $141.40 | +5.3% |
| FY2021 | $134.22 | +5.8% |
| FY2020 | $126.82 | +8.1% |
| FY2019 | $117.30 | +10.6% |
| FY2018 | $106.09 | +6.6% |
| FY2017 | $99.55 | +6.0% |
| FY2016 | $93.92 | +6.0% |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026